Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07549997

ENGAGE-TBI Feasibility Study

This study will first evaluate the feasibility of delivering the ENGAGE-TBI intervention in a community setting with adults with TBI.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Location contact

Curtis Comer, Clinical Research Coordinator I, High School

CONTACT

[email protected]

Jessica Kersey, PhD, OTR/L Assistant Professor, PhD, OTR/L

CONTACT

[email protected]

+1 314 273 7540

Jessica Kersey, PhD, OTR/L, PhD, OTR/L

PRINCIPAL_INVESTIGATOR

About this study

Social isolation is a prevalent and highly prioritized concern among people with traumatic brain injury (TBI), contributing to poor physical and mental health outcomes. Existing rehabilitation interventions have focused primarily on remediating underlying impairments, with limited success in improving social participation. A patient-directed, self-management approach may offer a promising alternative. This study aims to evaluate the feasibility of ENGAGE-TBI, a novel, theory-driven occupational therapy intervention designed to reduce social isolation by increasing social participation among community-dwelling adults with TBI. Using a single-group pre-post design, this study will enroll 30 adults with TBI recruited through the Brain Injury Association of Missouri. ENGAGE-TBI is a 12-session group intervention co-facilitated by an occupational therapist and a peer mentor with TBI. The intervention integrates three core elements - social learning, guided problem-solving, and skilled community practice - delivered across six weeks. Feasibility outcomes include fidelity, participant engagement, satisfaction, attendance, and retention. The primary clinical outcome is social participation, measured using the PROMIS Ability to Participate in Social Roles and Activities. Feasibility outcomes will be examined descriptively against pre-specified benchmarks. Within-group Cohen's d effect sizes with 95% confidence intervals will be calculated to estimate intervention effects and variability, informing the design of a future randomized controlled trial. Findings will support the development of a fully-powered effectiveness trial. This study addresses a critical gap in TBI rehabilitation by testing a stakeholder-informed, community-based intervention that treats TBI as a chronic condition and prioritizes patient-directed goal achievement over impairment remediation.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • at least 18 years old
  • experienced a TBI > 6 months prior to enrollment, confirmed by a physician as documented in their medical record
  • live in the St. Louis area
  • report problems with social participation (retention of < 80% of pre-TBI social activities as measured by Activity Card Sort)

Exclusion criteria

  • insufficient English language fluency to participate in the group intervention
  • have active substance use disorder (PRIME-MD MINI)
  • have an untreated psychotic disorder (PRIME-MD MINI)
  • have severe memory impairment that would limit their ability to recall strategies with support (Montreal Cognitive Assessment, < 21)

Treatment and study plan

Social intervention study for TBI survivors

Behavioral

ENGAGE-TBI is a community-based group intervention that is co-facilitated by an occupational therapist and a person with a brain injury. ENGAGE-TBI incorporates social learning, guided problem-solving, and skilled practice of strategies to achieve social participation goals. It is delivered in 12 90-minute group sessions that are held twice per week for 6 weeks. Aside from community outings, sessions will take place at the Brain Injury Association of Missouri on a separate day and time from education group sessions.

Primary outcomes

  1. Client Satisfaction Questionnaire-8

    Time frame: Post-Treatment (6-weeks)

    8-item measure of intervention satisfaction with a 4-point Likert scale (8-32); higher scores indicate greater satisfaction

  2. Pittsburgh Rehabilitation Participation Scale

    Time frame: Immediately at the conclusion of each intervention session (included as part of the interventionist's session documentation)

    Interventionist-administered measure of engagement in each intervention session; reported on a 1-6 scale, with higher scores indicating greater participation.

  3. PROMIS (Patient-Reported Outcome Measures Information System) Ability to Participate in Social Roles and Activities

    Time frame: Baseline, Post-Treatment (6-weeks)

    Computer adaptive test examining social participation abilities; scores reported as T-scores (0-100 scale, with higher scores indicating greater participation)

Secondary outcomes

  1. PROMIS (Patient-Reported Outcome Measures Information System) Social Isolation

    Time frame: Baseline, Post-Treatment (6-weeks)

    Computer Adaptive Test examining social isolation; scores reported as T-scores (0-100 scale, higher scores indicate higher isolation)

  2. PROMIS-29 (Patient-Reported Outcome Measures Information System)

    Time frame: Baseline, Post-Treatment (6-weeks)

    29-item measure of multiple health domains using a 5-point Likert scale and reported as T-scores (0-100 scale, lower scores indicate greater health)

Study contacts

Contact information is provided by the study sponsor or research team.

Curtis Comer, Clinical Research Coordinator I, High School

CONTACT

[email protected]

+1 314 273 3288

Jessica Kersey, PhD, OTR/L Assistant Professor, PhD, OTR/L

CONTACT

[email protected]

+1 314 273 7540

Sponsors and collaborators

Lead sponsor

Washington University School of Medicine

Other

Collaborators

  • American Occupational Therapy Foundation

Registry information

Important dates

Study start
2026
Primary completion
2027
Study completion
2028
First posted
Apr 24, 2026
Registry last updated
Apr 28, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.